» Articles » PMID: 23307531

Hormonal and Reproductive Risk Factors for Epithelial Ovarian Cancer by Tumor Aggressiveness

Abstract

Background: Approximately half of epithelial ovarian cancers are fatal within 3 years; however, roughly 35% of women survive for at least 10 years. In the Nurses' Health Study, New England Case-Control Study, Australian Ovarian Cancer Study, and NIH-AARP Diet and Health Study, we investigated potential differences in the associations with ovarian cancer risk factors by tumor aggressiveness, defined on the basis of time from diagnosis until death.

Methods: We calculated relative risks (RR) and 95% confidence intervals (CI) for associations of known or suspected ovarian cancer risk factors with rapidly fatal (death within 3 years of diagnosis) and less aggressive tumors (all others) using Cox proportional hazards competing risks analysis (NHS and AARP) or polytomous logistic regression (NECC, AOCS). Results were combined using random effects meta-analysis.

Results: Increasing age was associated with greater risk of rapidly fatal versus less aggressive disease (RR, 5-year increase: 1.39; 95% CI, 1.29-1.49 vs. RR, 1.09; 95% CI, 1.03-1.16, respectively; Pdiff < 0.0001). Oral contraceptive use was associated with a greater decreased risk of rapidly fatal (RR, 5-year increase: 0.69; 95% CI, 0.58-0.82) versus less aggressive disease (RR, 0.81; 95% CI, 0.74-0.89; Pdiff, 0.002). Conversely, increasing parity was associated only with less aggressive disease (RR per child, 0.87; 95% CI, 0.81-0.93).

Conclusion: In this analysis of 4,342 cases, there were clear differences in risk factors for rapidly fatal versus less aggressive ovarian tumors.

Impact: Differences in risk factor associations by tumor aggressiveness suggests the developmental pathways through which the tumors develop and may be important for developing primary preventive strategies for the most aggressive cancers.

Citing Articles

Impact of Pre-Diagnostic Risk Factors on Short- and Long-Term Ovarian Cancer Survival Trajectories: A Longitudinal Observational Study.

Kim S, Tworoger S, Rosen B, McLaughlin J, Risch H, Narod S Cancers (Basel). 2024; 16(5).

PMID: 38473333 PMC: 11154316. DOI: 10.3390/cancers16050972.


High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report.

Giancontieri P, Turetta C, Barchiesi G, Pernazza A, Pignataro G, DOnghia G Front Oncol. 2024; 13:1307573.

PMID: 38370346 PMC: 10870410. DOI: 10.3389/fonc.2023.1307573.


The Use of Lipid-based Nanocarriers to Improve Ovarian Cancer Treatment: An Overview of Recent Developments.

Tantray J, Patel A, Prajapati B, Kosey S, Bhattacharya S Curr Pharm Biotechnol. 2024; 25(17):2200-2217.

PMID: 38357950 DOI: 10.2174/0113892010279572240126052844.


Deciphering the Therapeutic Applications of Nanomedicine in Ovarian Cancer Therapy: An Overview.

Mathur P, Bhatt S, Kumar S, Kamboj S, Kamboj R, Rana A Curr Drug Deliv. 2023; 21(9):1180-1196.

PMID: 37818568 DOI: 10.2174/0115672018253815230922070558.


Imaging ovarian cancer - from baseline characteristics to high-risk image factors.

Sartor H, Bjurberg M, Asp M, Kahn A, Brandstedt J, Kannisto P J Ovarian Res. 2023; 16(1):78.

PMID: 37069618 PMC: 10108495. DOI: 10.1186/s13048-023-01154-w.


References
1.
Lund E . Mortality from ovarian cancer among women with many children. Int J Epidemiol. 1992; 21(5):872-6. DOI: 10.1093/ije/21.5.872. View

2.
Schatzkin A, Subar A, Thompson F, Harlan L, Tangrea J, Hollenbeck A . Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol. 2001; 154(12):1119-25. DOI: 10.1093/aje/154.12.1119. View

3.
Rosner B, Glynn R, Tamimi R, Chen W, Colditz G, Willett W . Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers. Am J Epidemiol. 2013; 178(2):296-308. PMC: 3816337. DOI: 10.1093/aje/kws457. View

4.
Whiteman D, Murphy M, Cook L, Cramer D, Hartge P, Marchbanks P . Multiple births and risk of epithelial ovarian cancer. J Natl Cancer Inst. 2000; 92(14):1172-7. DOI: 10.1093/jnci/92.14.1172. View

5.
Webb P, Ibiebele T, Hughes M, Beesley J, van der Pols J, Chen X . Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer. Eur J Clin Nutr. 2011; 65(10):1133-40. DOI: 10.1038/ejcn.2011.99. View